Ifosfamide-Induced Metabolic Encephalopathy in 2 Patients With Cutaneous T-Cell Lymphoma Successfully Treated With Methylene Blue

• Main Authors: Anusha Vakiti MD (Author), Ravi Pilla MD (Author), Muhamad Alhaj Moustafa MD (Author), Jacinth J. Joseph MD (Author), Aarthi G. Shenoy MD (Author)
• Format: Book
• Published: SAGE Publishing, 2018-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Ifosfamide, an alkylating agent used in cancer treatments, can cause neurotoxicity. The clinical presentation can range from mild symptoms such as acute confusion to non-convulsive seizures, severe irreversible coma, and death. The benefit of methylene blue use in treating ifosfamide-induced metabol...